Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
NCT Number: NCT07081295
The electrical impedance tomography (EIT) is a bedside, non-invasive, non-radiation imaging tool for lung mornitoring. Currently, the EIT saline-contrast method for lung perfusion evaluation has been widely used in clinical. However, this technique requires the patient to hold breath for 8-30s to avoid the respiratory interference. Hence, it is not suitable for patients that can not tolerate breath hold or unable to maintain a steady apnoea. This study aims to develop an algorithm system based on low frequency band pass filter for EIT saline-contrast lung perfusion estimation without ventilation interruption, and investigate the correlation and agreement of EIT results between the novel method and the conventional breath-hold method.
Looking for future studies?
Notify Me18 year–79 year
All sexes
Interventional
Not applicable
Beijing, Beijing Municipality, 100730, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Injection 10 mL of 10% NaCl through central venous catheter
Time frame: Offline analysis, immediately after the saline injection procedure
Time frame: Offline analysis, immediately after the saline injection procedure
Looking for future studies?
Notify MePeking Union Medical College Hospital
Other
A Novel Saline-contrast EIT Method for Lung Perfusion Estimation: Without Breath Hold by Low Frequency Band Pass Filter
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06887335
Lung Diseases, Respiratory Tract Diseases
Yangsan, South Korea
View Trial DetailsNCT06546839
Lung Cancer, Lung Cancer Metastatic
Istanbul, Bagcilar, Turkey (Türkiye)
View Trial DetailsNCT03641677
Lung Diseases, Respiratory Tract Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT05459155
Cardiovascular Diseases, Digestive System Diseases
Boston, Massachusetts, United States
View Trial Details